Learn more

UNIV LOMA LINDA

Overview
  • Total Patents
    279
  • GoodIP Patent Rank
    13,087
  • Filing trend
    ⇧ 100.0%
About

UNIV LOMA LINDA has a total of 279 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1966. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are MASSACHUSETTS EYE & EAR INFIRMARY, Tianjin cancer hospital and SCHEPENS EYE RES INST.

Patent filings per year

Chart showing UNIV LOMA LINDAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Escher Alan P 66
#2 Li Fengchun 38
#3 Baylink David J 21
#4 Lau Kin-Hing William 17
#5 Schulte Reinhard W 16
#6 Arakawa Takeshi 14
#7 Langridge William H R 14
#8 Filippova Maria 13
#9 Szalay Aladar A 12
#10 Liu Jingxue 12

Latest patents

Publication Filing date Title
WO2021034534A1 Anatomically aligned prosthetic ankle
WO2020210798A1 Methods for treatment of niemann-pick disease type c
WO2020028562A1 Snail sirna-loaded mesoporous silica nanoparticles
WO2020006504A1 Anabolic targeting stem cell gene therapy for osteoporosis
CA3103423A1 Engineered hematopoietic stem cells for the treatment of acute myeloid leukemia
EP3801221A1 Methods of delaying and reversing alzheimer's disease progression
EP3784195A1 Computer-supported intraneural facilitation for vascular changes
WO2019173704A1 Apparatus, device, method, and kit for infant gavage feeding
US2020375500A1 Systems and methods for detection and correction of abnormal movements
AU2018360514A1 Methods for treating traumatic brain injury
AU2018248423A1 Biologic for the treatment of cancer
WO2018183780A1 Modular pedicle screw assemblies and associated methods
WO2018129082A1 Syringe steadying device, kit, and associated methods
AU2017379813A1 Methods and systems for implant identification using imaging data
US2019248867A1 Myelin oligodendrocyte glycoprotein-specific peptide for the treatment or prevention of multiple sclerosis
WO2017214190A1 Engineered dendritic cells that express 1a-hydroxylase and uses thereof for treating immune-mediated diseases
WO2017075518A1 Integrated phototherapy apparatus and methods
WO2017075089A1 System and method to analyze various retinal layers
WO2017066358A1 Methods and systems to perform proton computed tomography
US2017028220A1 Systems and methods for intensity modulated radiation therapy